Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Joller-Jemelka

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
International Archives of Allergy and Applied Immunology|January 1, 1984
IgG subclasses of anti-HBs antibodies in vaccinated and nonvaccinated individuals and in anti-HBs immunoglobulin preparationsF Skvaril, H Joller-Jemelka
Lancet (London, England)|June 12, 1993
Indeterminate hepatitis CA N Wicki, H Joller-Jemelka
Schweizerische Medizinische Wochenschrift|August 29, 1987
[HIV serology in the early stage of an HIV infection]H Joller-Jemelka, P J Grob
Archives of Dermatological Research|January 1, 1992
Soluble CD14 but not interleukin-6 is a new marker for clinical activity in atopic dermatitisB Wüthrich, M K Kägi, H Joller-Jemelka
Schweizerische Medizinische Wochenschrift|November 2, 1985
[Thyroid antibodies and their diagnostic value]P Schneidinger, H Joller-Jemelka, P J Grob
Allergy|April 9, 1999
Soluble E-selectin correlates with disease activity in cyclosporin A-treated patients with atopic dermatitisM K Kägi, H Joller-Jemelka, B Wüthrich
Allergy|January 1, 1995
Levels of soluble ICAM-1 in atopic dermatitis. A new marker for monitoring the clinical activity?B Wüthrich, H Joller-Jemelka, M K Kägi
Dermatology (Basel, Switzerland)|January 1, 1992
Correlation of eosinophils, eosinophil cationic protein and soluble interleukin-2 receptor with the clinical activity of atopic dermatitisM K Kägi, H Joller-Jemelka, B Wüthrich
Dermatologica|January 1, 1990
Levels of soluble interleukin-2 receptors correlate with the severity of atopic dermatitisB Wüthrich, H Joller-Jemelka, U Helfenstein, et al.
Journal of Perinatal Medicine|January 1, 1995
Pregnancy, immunosuppression and reactivation of latent toxoplasmosisK Biedermann, M Flepp, W Fierz, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
International Archives of Allergy and Applied Immunology|January 1, 1984
IgG subclasses of anti-HBs antibodies in vaccinated and nonvaccinated individuals and in anti-HBs immunoglobulin preparationsF Skvaril, H Joller-Jemelka
Lancet (London, England)|June 12, 1993
Indeterminate hepatitis CA N Wicki, H Joller-Jemelka
Schweizerische Medizinische Wochenschrift|August 29, 1987
[HIV serology in the early stage of an HIV infection]H Joller-Jemelka, P J Grob
Archives of Dermatological Research|January 1, 1992
Soluble CD14 but not interleukin-6 is a new marker for clinical activity in atopic dermatitisB Wüthrich, M K Kägi, H Joller-Jemelka
Schweizerische Medizinische Wochenschrift|November 2, 1985
[Thyroid antibodies and their diagnostic value]P Schneidinger, H Joller-Jemelka, P J Grob
Allergy|April 9, 1999
Soluble E-selectin correlates with disease activity in cyclosporin A-treated patients with atopic dermatitisM K Kägi, H Joller-Jemelka, B Wüthrich
Allergy|January 1, 1995
Levels of soluble ICAM-1 in atopic dermatitis. A new marker for monitoring the clinical activity?B Wüthrich, H Joller-Jemelka, M K Kägi
Dermatology (Basel, Switzerland)|January 1, 1992
Correlation of eosinophils, eosinophil cationic protein and soluble interleukin-2 receptor with the clinical activity of atopic dermatitisM K Kägi, H Joller-Jemelka, B Wüthrich
Dermatologica|January 1, 1990
Levels of soluble interleukin-2 receptors correlate with the severity of atopic dermatitisB Wüthrich, H Joller-Jemelka, U Helfenstein, et al.
Journal of Perinatal Medicine|January 1, 1995
Pregnancy, immunosuppression and reactivation of latent toxoplasmosisK Biedermann, M Flepp, W Fierz, et al.
Pageof 2